Top news
NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19
Fauci says leak concerns fueled his White House revelation of Gilead drug results
By Julie Steenhuysen
Gilead's remdesivir shows some benefit in early results as coronavirus treatment - The Washington Post
By Laurie McGinley & Christopher Rowland
All coverage
Trump wants FDA to move 'as quickly as they can' on remdesivir coronavirus approval
By Berkeley Lovelace & Berkeley Lovelace Jr.
FDA issues emergency-use authorization for remdesivir in hospitalized coronavirus patients in severe condition
By Arman Azad & Nicole Chavez
Remdesivir-Maker Gilead's Lobbying Hit New High In 1st Quarter : Shots - Health News
By Sydney Lupkin
Remdesivir Shows Modest Benefits in Coronavirus Trial
By Gina Kolata, Peter Baker & Noah Mercer Weiland
FDA OKs Gilead Coronavirus Drug Remdesivir Emergency Use: Trump
By Anna Edney, Michelle Cortez & Justin Sink
Remdesivir: the antiviral drug is being touted as a possible coronavirus treatment – but will it work?
By Melissa Davey
Remdesivir shows success in large COVID-19 trial. Will become 'new standard of care,' Fauci says.
By Nicoletta Lanese
Fauci praises remdesivir after data show it speeds recovery
By Donato Paolo Mancini & Hannah Kuchler
Dr. Anthony Fauci says Gilead's remdesivir will set a new 'standard of care' for coronavirus treatment
By Berkeley Lovelace & Berkeley Lovelace Jr.
Critical study of Gilead's Covid-19 drug shows patients are responding to treatment, NIH says
By Adam Feuerstein & Matthew Herper